- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Drug Pipelines
- April 2024
- 280 Pages
Global
From €2730EUR$3,000USD£2,341GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1138EUR$1,250USD£975GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Drug Pipelines
- February 2024
- 80 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2023
- 160 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- April 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- September 2024
- 80 Pages
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2022
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- December 2022
- 72 Pages
Global
From €3181EUR$3,495USD£2,727GBP
- Report
- November 2018
- 49 Pages
Global
From €3181EUR$3,495USD£2,727GBP
- Report
- May 2023
- 215 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- May 2023
- 93 Pages
Europe
From €1365EUR$1,500USD£1,170GBP
- Report
- May 2023
- 93 Pages
Africa, Middle East
From €1365EUR$1,500USD£1,170GBP
- Report
- May 2023
- 83 Pages
North America
From €1365EUR$1,500USD£1,170GBP
- Report
- May 2023
- 94 Pages
Asia Pacific
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
United States
From €1766EUR$1,940USD£1,514GBP

The Influenza Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory illnesses, such as asthma, COPD, and cystic fibrosis. Influenza drugs are used to treat the symptoms of the flu, such as fever, cough, and sore throat. These drugs can also help reduce the risk of complications from the flu, such as pneumonia. Commonly used influenza drugs include antivirals, such as oseltamivir and zanamivir, and anti-inflammatory drugs, such as ibuprofen and acetaminophen.
Some companies in the Influenza Drug market include GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Other companies include Roche, Merck, and Pfizer. Show Less Read more